Clinical Trial Update: A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating latanoprost, timolol, and their combination for eye pressure reduction in open-angle glaucoma and ocular hypertension; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Latanoprost (Latanoprost)
• Timolol (timolol)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Ocular Hypertension, Glaucoma | Phase 3 | Status: COMPLETED